These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24140122)

  • 61. The Mexican schedule to conduct allogeneic stem cell transplantation is related to a low risk of cytomegalovirus reactivation and disease.
    Ruiz-Argüelles GJ; Rangel JD; Ponce-de-León S; González-Déctor L; Reyes-Núñez V; Garcés-Eisele J
    Am J Hematol; 2004 Apr; 75(4):200-4. PubMed ID: 15054809
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity.
    Boeckh M; Leisenring W; Riddell SR; Bowden RA; Huang ML; Myerson D; Stevens-Ayers T; Flowers ME; Cunningham T; Corey L
    Blood; 2003 Jan; 101(2):407-14. PubMed ID: 12393659
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.
    Barron MA; Gao D; Springer KL; Patterson JA; Brunvand MW; McSweeney PA; Zeng C; Barón AE; Weinberg A
    Clin Infect Dis; 2009 Dec; 49(12):1777-83. PubMed ID: 19911937
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Bone Marrow Transplant; 2008 Nov; 42(10):673-7. PubMed ID: 18695666
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cytomegalovirus reactivation following hematopoietic stem cell transplantation.
    Sharma SK; Kumar S; Agrawal N; Singh L; Mukherjee A; Seth T; Mishra P; Mathur S; Dar L; Mahapatra M
    J Infect Dev Ctries; 2013 Dec; 7(12):1003-7. PubMed ID: 24334950
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation.
    Alexandersson A; Venäläinen MS; Heikkilä N; Huang X; Taskinen M; Huttunen P; Elo LL; Koskenvuo M; Kekäläinen E
    Immunol Cell Biol; 2024 Jul; 102(6):513-525. PubMed ID: 38726587
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation.
    Avetisyan G; Larsson K; Aschan J; Nilsson C; Hassan M; Ljungman P
    Bone Marrow Transplant; 2006 Nov; 38(10):687-92. PubMed ID: 17001346
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prospective validation of the L-index reflecting both the intensity and duration of lymphopenia and its detailed evaluation using a lymphocyte subset analysis after allogeneic hematopoietic stem cell transplantation.
    Kimura SI; Sato M; Misaki Y; Yoshimura K; Gomyo A; Hayakawa J; Akahoshi Y; Harada N; Tamaki M; Kusuda M; Kameda K; Wada H; Kawamura K; Terasako-Saito K; Kikuchi M; Tanihara A; Nakasone H; Kako S; Kanda Y
    Transpl Immunol; 2020 Feb; 58():101262. PubMed ID: 31899256
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME).
    Thiele T; Krüger W; Zimmermann K; Ittermann T; Wessel A; Steinmetz I; Dölken G; Greinacher A
    Transfusion; 2011 Dec; 51(12):2620-6. PubMed ID: 21645009
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
    Crippa F; Corey L; Chuang EL; Sale G; Boeckh M
    Clin Infect Dis; 2001 Jan; 32(2):214-9. PubMed ID: 11170910
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation.
    Morita-Hoshi Y; Heike Y; Kawakami M; Sugita T; Miura O; Kim SW; Mori SI; Fukuda T; Tanosaki R; Tobinai K; Takaue Y
    Bone Marrow Transplant; 2008 Mar; 41(6):515-21. PubMed ID: 18026143
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.
    Jaskula E; Dlubek D; Tarnowska A; Lange J; Mordak-Domagala M; Suchnicki K; Sedzimirska M; Borowik A; Mizia S; Lange A
    Viruses; 2015 Mar; 7(3):1391-408. PubMed ID: 25807050
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CMV-specific immune reconstitution following allogeneic stem cell transplantation.
    Blyth E; Withers B; Clancy L; Gottlieb D
    Virulence; 2016 Nov; 7(8):967-980. PubMed ID: 27580355
    [TBL] [Abstract][Full Text] [Related]  

  • 75. STAT5 phosphorylation in T cell subsets from septic patients in response to recombinant human interleukin-7: a pilot study.
    Demaret J; Dupont G; Venet F; Friggeri A; Lepape A; Rimmelé T; Morel J; Monneret G
    J Leukoc Biol; 2015 Apr; 97(4):791-6. PubMed ID: 25691382
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yong MK; Cameron PU; Slavin M; Morrissey CO; Bergin K; Spencer A; Ritchie D; Cheng AC; Samri A; Carcelain G; Autran B; Lewin SR
    J Infect Dis; 2017 Jun; 215(11):1684-1694. PubMed ID: 28431019
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evolution of peripheral blood T lymphocyte subsets after allogenic or autologous hematopoietic stem cell transplantation.
    Puissant-Lubrano B; Huynh A; Attal M; Blancher A
    Immunobiology; 2014 Aug; 219(8):611-8. PubMed ID: 24721705
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytomegalovirus infection is associated with thymic dysfunction and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation.
    Kielsen K; Møller DL; Pedersen AE; Nielsen CH; Ifversen M; Ryder LP; Müller K
    Clin Immunol; 2024 Aug; 265():110302. PubMed ID: 38942161
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of human cytomegalovirus (CMV) DNA in feces has limited value in predicting CMV enteritis in patients with intestinal graft-versus-host disease after allogeneic stem cell transplantation.
    Sun YQ; Xu LP; Han TT; Zhang XH; Wang Y; Han W; Wang FR; Wang JZ; Chen H; Chen YH; Yan CH; Chen Y; Liu KY; Huang XJ
    Transpl Infect Dis; 2015 Oct; 17(5):655-61. PubMed ID: 26275161
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation.
    Nishihori T; Shaheen M; El-Asmar J; Aljurf M; Kharfan-Dabaja MA
    Immunotherapy; 2015; 7(10):1059-71. PubMed ID: 26507225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.